OpenURL Connection Search

Select item for more details and to access through your institution.

Depletion of Glutathione in Normal and Malignant Human Cells In Vivo by Buthionine Sulfoximine: Clinical and Biochemical Results.
Published in:
JNCI: Journal of the National Cancer Institute, 1992, v. 84, n. 4, p. 264, doi. 10.1093/jnci/84.4.264
By:
- O'Dwyer, P. J.;
- Hamilton, T. C.;
- Young, R. C.;
- LaCreta, F. P.;
- Carp, N.;
- Tew, K. D.;
- Padavic, K.;
- Comis, R. L.;
- Ozols, R. F.
Publication type:
Article
Effect of a high-fat meal on the pharmacokinetics of dapagliflozin, a selective SGLT2 inhibitor, in healthy subjects.
Published in:
Diabetes, Obesity & Metabolism, 2011, v. 13, n. 8, p. 770, doi. 10.1111/j.1463-1326.2011.01397.x
By:
- Kasichayanula, S.;
- Liu, X.;
- Zhang, W.;
- Pfister, M.;
- Reele, S. B.;
- Aubry, A.-F.;
- LaCreta, F. P.;
- Boulton, D. W.
Publication type:
Article
Pharmacokinetics and pharmacodynamics of dapagliflozin, a novel selective inhibitor of sodium-glucose co-transporter type 2, in Japanese subjects without and with type 2 diabetes mellitus.
Published in:
Diabetes, Obesity & Metabolism, 2011, v. 13, n. 4, p. 357, doi. 10.1111/j.1463-1326.2011.01359.x
By:
- Kasichayanula, S.;
- Chang, M.;
- Hasegawa, M.;
- Liu, X.;
- Yamahira, N.;
- LaCreta, F. P.;
- Imai, Y.;
- Boulton, D. W.
Publication type:
Article
Lack of pharmacokinetic interaction between dapagliflozin, a novel sodium-glucose transporter 2 inhibitor, and metformin, pioglitazone, glimepiride or sitagliptin in healthy subjects.
Published in:
Diabetes, Obesity & Metabolism, 2011, v. 13, n. 1, p. 47, doi. 10.1111/j.1463-1326.2010.01314.x
By:
- Kasichayanula, S.;
- Liu, X.;
- Shyu, W. C.;
- Zhang, W.;
- Pfister, M.;
- Griffen, S. C.;
- Li, T.;
- LaCreta, F. P.;
- Boulton, D. W.
Publication type:
Article
Effects of rifampin and mefenamic acid on the pharmacokinetics and pharmacodynamics of dapagliflozin.
Published in:
Diabetes, Obesity & Metabolism, 2013, v. 15, n. 3, p. 280, doi. 10.1111/dom.12024
By:
- Kasichayanula, S.;
- Liu, X.;
- Griffen, S. C.;
- LaCreta, F. P.;
- Boulton, D. W.
Publication type:
Article
Differential Effects of Omeprazole and Pantoprazole on the Pharmacodynamics and Pharmacokinetics of Clopidogrel in Healthy Subjects: Randomized, Placebo-Controlled, Crossover Comparison Studies.
Published in:
Clinical Pharmacology & Therapeutics, 2011, v. 89, n. 1, p. 65, doi. 10.1038/clpt.2010.219
By:
- Angiolillo, D. J.;
- Gibson, C. M.;
- Cheng, S.;
- Ollier, C.;
- Nicolas, O.;
- Bergougnan, L.;
- Perrin, L.;
- LaCreta, F. P.;
- Hurbin, F.;
- Dubar, M.
Publication type:
Article

Found: 6

Depletion of Glutathione in Normal and Malignant Human Cells In Vivo by Buthionine Sulfoximine: Clinical and Biochemical Results.

Effect of a high-fat meal on the pharmacokinetics of dapagliflozin, a selective SGLT2 inhibitor, in healthy subjects.

Pharmacokinetics and pharmacodynamics of dapagliflozin, a novel selective inhibitor of sodium-glucose co-transporter type 2, in Japanese subjects without and with type 2 diabetes mellitus.

Lack of pharmacokinetic interaction between dapagliflozin, a novel sodium-glucose transporter 2 inhibitor, and metformin, pioglitazone, glimepiride or sitagliptin in healthy subjects.

Effects of rifampin and mefenamic acid on the pharmacokinetics and pharmacodynamics of dapagliflozin.

Differential Effects of Omeprazole and Pantoprazole on the Pharmacodynamics and Pharmacokinetics of Clopidogrel in Healthy Subjects: Randomized, Placebo-Controlled, Crossover Comparison Studies.